Model-Based Drug Development in Pulmonary Delivery: Pharmacokinetic Analysis of Novel Drug Candidates for Treatment of Pseudomonas aeruginosa Lung Infection-Reference-Cited by-同舟云学术

Model-Based Drug Development in Pulmonary Delivery: Pharmacokinetic Analysis of Novel Drug Candidates for Treatment of Pseudomonas aeruginosa Lung Infection

Published:2019-01 Issue:1 Volume:108 Page:630-640
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Sou Tomás,Kukavica-Ibrulj Irena,Soukarieh Fadi,Halliday Nigel,Levesque Roger C.,Williams Paul,Stocks Michael,Cámara Miguel,Friberg Lena E.,Bergström Christel A.S.

Funder

Medical Research Council

Biotechnology and Biological Sciences Research Council

Joint Programming Initiative on Antimicrobial Resistance

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options;Chatterjee;Int J Med Microbiol,2016

2. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients;Ciofu;Adv Drug Deliv Rev,2015

3. Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time;Crull;BMC Pulm Med,2016